Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Articles|December 31, 2006
Treating a Subungual Abscess? Here’s the Drill
Instead of nail removal, another option for treating a subungualabscess is to scrub the digit and drill a hole in thenail plate with a hot wire loop.
Advertisement
Instead of nail removal, another option for treating a subungualabscess is to scrub the digit and drill a hole in thenail plate with a hot wire loop. The pus drains through thehole. This faster and less invasive procedure also savesthe patient's nail.-- Matthew J. Nelsen, MD
Carmel, Ind
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
4
Clinical Inertia and Poor Measurement Technique Undermine BP Control
5